Vertex Pharmaceuticals Incorporated (BMV:VRTX)

Mexico flag Mexico · Delayed Price · Currency is MXN
7,166.00
+152.71 (2.18%)
At close: Aug 12, 2025
-19.07%
Market Cap 1.88T
Revenue (ttm) 215.34B
Net Income (ttm) 68.60B
Shares Out n/a
EPS (ttm) 265.34
PE Ratio 27.45
Forward PE 19.74
Dividend n/a
Ex-Dividend Date n/a
Volume 152
Average Volume 698
Open 7,164.00
Previous Close 7,013.29
Day's Range 7,150.00 - 7,170.00
52-Week Range 7,013.29 - 10,477.52
Beta 0.44
RSI 36.68
Earnings Date Aug 4, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 6,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.